Aberrant T Helper 17 Cells and Related Cytokines in Bone Marrow Microenvironment of Patients with Acute Myeloid Leukemia

Figure 1

BM Th17 and Th1 cells in representative patients with ND, CR, and relapsed-refractory AML and controls. (a) 5000 CD4⁺ cells were collected by flow cytometry. (b) CD4⁺ lymphocytes were gated. (c), (d), (e), and (f) The percentages of BM Th17 (CD4⁺ IL-17⁺) cells in ND, CR, and relapsed-refractory AML patients and controls. (g), (h), (i), and (j) The percentages of BM Th1 (CD4⁺ IFN-γ ⁺) cells in ND, CR, and relapsed-refractory AML patients and controls.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)